Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Objective Using genome-wide promoter methylation assay, B cell CLL/lymphoma 6 member B (BCL6B) was found to be preferentially methylated in cancer. A study was undertaken to examine the epigenetic regulation, biological function and clinical significance of BCL6B in gastric cancer (GC).
著者Xu LX, Li XX, Chu ESH, Zhao GJ, Go MNYY, Tao Q, Jin HC, Zeng ZR, Sung JJY, Yu J
期刊名稱Gut
出版年份2012
月份7
日期1
卷號61
期次7
出版社B M J PUBLISHING GROUP
頁次977 - 985
國際標準期刊號0017-5749
電子國際標準期刊號1468-3288
語言英式英語
Web of Science 學科類別Gastroenterology & Hepatology; GASTROENTEROLOGY & HEPATOLOGY

上次更新時間 2020-25-10 於 01:23